PRMT5 was overexpressed in CD138+ immunopurified cells derived from patients with MM, and the upregulation of PRMT5 was closely related to the decreased OS and progression-free survival rates [71]. The gene discussed is PRMT5; the disease is Miyoshi myopathy.